Maze Therapeutics, Inc. (MAZE) Institutional Ownership & Insider Trading
162 institutions reported holding Maze Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 95 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MAZEMaze Therapeutics, Inc.Follow MAZE — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters162 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +11.5%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 162 | 59 | +11.5% | 65 | 36 | 36 | 36 |
| Mar 26 | 165 | 52 | +6.8% | 57 | 42 | 36 | 23 |
| Dec 25 | 142 | 48 | +10.8% | 46 | 49 | 18 | 8 |
| Sep 25 | 93 | 43 | +10.8% | 37 | 23 | 14 | 2 |
| Jun 25 | 74 | 39 | -3.0% | 24 | 13 | 12 | 6 |
| Mar 25 | 68 | 40 | — | — | — | — | — |
Maze Therapeutics, Inc. — questions
- Who owns Maze Therapeutics, Inc. stock?
- 162 institutions reported Maze Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Frazier Life Sciences Management, L.P. (9.1%), TRV GP IV, LLC (8.1%), ARCH Venture Management, LLC (7.4%).
- Are Maze Therapeutics, Inc. insiders buying or selling?
- 95 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Maze Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.